83 FR 14466 - Center For Scientific Review; Notice of Closed Meeting
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health Federal Register Volume 83, Issue 65 (April 4, 2018)
National Institutes of Health
Federal Register Volume 83, Issue 65 (April 4, 2018)
| Page Range | 14466-14466 | |
| FR Document | 2018-06839 |
[Federal Register Volume 83, Number 65 (Wednesday, April 4, 2018)] [Notices] [Page 14466] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2018-06839] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center For Scientific Review; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR-16-115: Optimization of Monoclonal Antibodies for Eliminating the HIV Reservoir. Date: April 18, 2018. Time: 1:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Robert Freund, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5216, MSC 7852, Bethesda, MD 20892, 301-435- 1050, [email protected]. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: March 30, 2018. Natasha M. Copeland, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2018-06839 Filed 4-3-18; 8:45 am] BILLING CODE 4140-01-P
![14466 Federal Register / Vol. 83, No. 65 / Wednesday, April 4, 2018 / Notices
Place: National Institutes of Health, 5601 Place: National Institutes of Health, 6701 (Catalogue of Federal Domestic Assistance
Fishers Lane, Rockville, MD 20892 Rockledge Drive, Bethesda, MD 20892 Program Nos. 93.306, Comparative Medicine;
(Telephone Conference Call). (Telephone Conference Call). 93.333, Clinical Research, 93.306, 93.333,
Contact Person: Robert C. Unfer, Ph.D., Contact Person: Robert Freund, Ph.D., 93.337, 93.393–93.396, 93.837–93.844,
Scientific Review Officer, Scientific Review Scientific Review Officer, Center for 93.846–93.878, 93.892, 93.893, National
Program, DEA/NIAID/NIH/DHHS, 5601 Scientific Review, National Institutes of Institutes of Health, HHS)
Fishers Lane, Room 3F40, MSC 9823, Health, 6701 Rockledge Drive, Room 5216,
Rockville, MD 20892–9823, 240–669–5035, MSC 7852, Bethesda, MD 20892, 301–435– Dated: March 29, 2018.
unferrc@nih.gov. 1050, freundr@csr.nih.gov. Melanie J. Pantoja,
Name of Committee: National Institute of This notice is being published less than 15 Program Analyst, Office of Federal Advisory
Allergy and Infectious Diseases Special days prior to the meeting due to the timing Committee Policy.
Emphasis Panel; RFA–HL–18–023: limitations imposed by the review and [FR Doc. 2018–06777 Filed 4–3–18; 8:45 am]
Stimulating Access to Research in Residency funding cycle.
BILLING CODE 4140–01–P
(StARR) (R38). (Catalogue of Federal Domestic Assistance
Date: April 27, 2018. Program Nos. 93.306, Comparative Medicine;
Time: 10:00 a.m. to 6:00 p.m. 93.333, Clinical Research, 93.306, 93.333,
Agenda: To review and evaluate grant 93.337, 93.393–93.396, 93.837–93.844, DEPARTMENT OF HEALTH AND
applications. 93.846–93.878, 93.892, 93.893, National HUMAN SERVICES
Place: National Institutes of Health, 5601 Institutes of Health, HHS)
Fishers Lane, Rockville, MD 20892 National Institutes of Health
(Telephone Conference Call). Dated: March 30, 2018.
Contact Person: Ann Marie M. Cruz, Ph.D., Natasha M. Copeland, National Cancer Institute; Notice of
Program Management & Operations Branch, Closed Meeting
Scientific Review Program, National Program Analyst, Office of Federal Advisory
Institutes of Health, NIAID, 5601 Fishers Committee Policy. Pursuant to section 10(d) of the
Lane, RM 3E71, Rockville, MD 20852, 301– [FR Doc. 2018–06839 Filed 4–3–18; 8:45 am] Federal Advisory Committee Act, as
761–3100, cruza@niaid.nih.gov. BILLING CODE 4140–01–P amended, notice is hereby given of the
(Catalogue of Federal Domestic Assistance following meeting.
Program Nos. 93.855, Allergy, Immunology, The meeting will be closed to the
and Transplantation Research; 93.856, DEPARTMENT OF HEALTH AND public in accordance with the
Microbiology and Infectious Diseases HUMAN SERVICES provisions set forth in sections 552b(c)
Research, National Institutes of Health, HHS)
(4) and 552b(c)(6), Title 5 U.S.C., as
Dated: March 30, 2018. National Institutes of Health amended. The purpose of this meeting
Natasha M. Copeland, is to evaluate requests for preclinical
Center for Scientific Review; Notice of
Program Analyst, Office of Federal Advisory development resources for potential
Committee Policy. Closed Meeting
new therapeutics for the treatment of
[FR Doc. 2018–06842 Filed 4–3–18; 8:45 am] Pursuant to section 10(d) of the cancer. The outcome of the evaluation
BILLING CODE 4140–01–P Federal Advisory Committee Act, as will provide information to internal NCI
amended, notice is hereby given of the committees that will decide whether
following meeting. NCI should support requests and make
DEPARTMENT OF HEALTH AND The meeting will be closed to the available contract resources for
HUMAN SERVICES public in accordance with the development of the potential
provisions set forth in sections therapeutic to improve the treatment of
National Institutes of Health 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., various forms of cancer. The research
as amended. The grant applications and proposals and the discussions could
Center For Scientific Review; Notice of
Closed Meeting the discussions could disclose disclose confidential trade secrets or
confidential trade secrets or commercial commercial property such as patentable
Pursuant to section 10(d) of the property such as patentable material, material, and personal information
Federal Advisory Committee Act, as and personal information concerning concerning individuals associated with
amended, notice is hereby given of the individuals associated with the grant the proposed research projects, the
following meeting. applications, the disclosure of which disclosure of which would constitute a
The meeting will be closed to the would constitute a clearly unwarranted clearly unwarranted invasion of
public in accordance with the invasion of personal privacy. personal privacy.
provisions set forth in sections Name of Committee: Center for Scientific Name of Committee: National Cancer
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Review Special Emphasis Panel; In vitro Institute Special Emphasis Panel; Feb2018
as amended. The grant applications and models of hepatoxicity. Cycle 28 NExT SEP Committee Meeting.
the discussions could disclose Date: April 11, 2018. Date: April 25, 2018.
confidential trade secrets or commercial Time: 2:00 p.m. to 3:00 p.m. Time: 8:30 a.m. to 4:30 p.m.
property such as patentable material, Agenda: To review and evaluate grant Agenda: To evaluate the NCI Experimental
and personal information concerning applications. Therapeutics Program Portfolio.
Place: National Institutes of Health, 6701 Place: National Institutes of Health, 9000
individuals associated with the grant Rockledge Drive, Bethesda, MD 20892
applications, the disclosure of which Rockville Pike, Building 31, Wing C; 6th
(Telephone Conference Call). Floor, Conference Room 10, Bethesda, MD
would constitute a clearly unwarranted Contact Person: Martha Garcia, Ph.D., 20892.
invasion of personal privacy. Scientific Reviewer Officer, Center for Contact Persons: Barbara Mroczkowski,
Scientific Review, National Institutes of
amozie on DSK30RV082PROD with NOTICES
Name of Committee: Center for Scientific Ph.D., Executive Secretary, Discovery
Review Special Emphasis Panel; PAR–16– Health, 6701 Rockledge Drive, Room 2186, Experimental Therapeutics Program,
115: Optimization of Monoclonal Antibodies MSC 7818, Bethesda, MD 20892, 301–435– National Cancer Institute, NIH, 31 Center
for Eliminating the HIV Reservoir. 1243, garciamc@nih.gov. Drive, Room 3A44, Bethesda, MD 20817,
Date: April 18, 2018. This notice is being published less than 15 (301) 496–4291, mroczkoskib@mail.nih.gov.
Time: 1:00 p.m. to 5:00 p.m. days prior to the meeting due to the timing Toby Hecht, Ph.D., Executive Secretary,
Agenda: To review and evaluate grant limitations imposed by the review and Development Experimental Therapeutics
applications. funding cycle. Program, National Cancer Institute, NIH,
VerDate Sep<11>2014 18:12 Apr 03, 2018 Jkt 244001 PO 00000 Frm 00057 Fmt 4703 Sfmt 4703 E:\FR\FM\04APN1.SGM 04APN1](https://thefederalregister.org/doc/83_FR_14531/page/1.svg)
Document Created: 2018-11-01 09:11:50
Document Modified: 2018-11-01 09:11:50
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Dates | April 18, 2018. | |
| FR Citation | 83 FR 14466 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR